2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ferumoxides: new trials by email Literature Review of ferumoxides trials Research Report on ferumoxides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran Ferucarbotran (Resovist) - Acute Myocardial Infarction | Phase 2 / Phase 3 | Completed | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | 20 | 2009-03-01 | 2014-11-07 |
| Identification of Hepatic Lesions Resovist (BAY86-4884, SH U 555 A) - Hepatic Neoplasms | Phase 3 | Completed | Bayer | 218 | 2001-04-01 | 2009-05-18 |
Liver Neoplasms (1)
Bayer (1) · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) (1)
Germany (1) · Italy (1)
Udo Sechtem, MD (1)